It would be important in future studies to determine whether the astrocytic activation indicated by elevated GFAP mRNA is found in brain regions affected by AD other than the temporal cortex, particularly the hippocampus, and whether the absence of evidence for NLRP3 activation also extends to these other areas. This evidence concerns the gene GFAP and Alzheimer disease.